Seeing Is Believing
Menlo Therapeutics's activity chart (see below) currently has 11 price targets and 7 ratings on display.
Analysts average stock forecasts to be materialized ratio is 9.09% with an average time for these price targets to be met of 2.64 days.
Most recent stock forecast was given by from on 01-Jun-2020. First documented stock forecast 09-Apr-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Jun-2020
$6
$-154.56 (-96.26%)
6 years 1 months 12 days ago
(01-Jun-2020)
0/1 (0%)
$-164.64 (-96.48%)
Buy Since 13-May-2020
$3
$-157.56 (-98.13%)
6 years 2 months ago
(13-May-2020)
0/1 (0%)
$-119.4 (-97.55%)
Buy Since 18-Oct-2019
$2.5
$-158.06 (-98.44%)
$9
6 years 2 months 1 days ago
(12-May-2020)
0/3 (0%)
$-127.82 (-98.08%)
Hold
$7
$4.77 (213.90%)
7 years 9 months 4 days ago
(09-Oct-2018)
1/1 (100%)
$0.74 (11.82%)
29
Buy Since 06-Sep-2018
$25
$-135.56 (-84.43%)
7 years 10 months 7 days ago
(06-Sep-2018)
0/1 (0%)
$-524.36 (-95.45%)
What is MNLO (Menlo Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on MNLO (Menlo Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MNLO (Menlo Therapeutics)?
Which analyst is the currently most bullish on MNLO (Menlo Therapeutics)?
Which analyst is the currently most reserved on MNLO (Menlo Therapeutics)?